Glucocorticoids are not always deleterious for bone (Q43022342)

12 November 2017

Glucocorticoids are not always deleterious for bone (English)

1 reference

12 November 2017

Antoon H J M van Lierop

series ordinal

1

1 reference

PubMed ID

20549703

12 November 2017

Neveen A T Hamdy

series ordinal

2

1 reference

PubMed ID

20549703

12 November 2017

Socrates E Papapoulos

series ordinal

3

1 reference

12 November 2017

1 December 2010

1 reference

Journal of Bone and Mineral Research

12 November 2017

1 reference

12 November 2017

25

1 reference

12 November 2017

12

1 reference

12 November 2017

2796-2800

1 reference

Van Buchem disease: lifetime evolution of radioclinical features

12 November 2017

1 reference

A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population

21 January 2018

1 reference

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

21 January 2018

1 reference

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

21 January 2018

1 reference

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

21 January 2018

1 reference

The natural history of sclerosteosis

21 January 2018

1 reference

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

21 January 2018

1 reference

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

21 January 2018

1 reference

Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal

21 January 2018

1 reference

Genetic analysis and effect of triiodothyronine and prednisone trial on bone turnover in a patient with craniotubular hyperostosis

21 January 2018

1 reference

Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment

21 January 2018

1 reference

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

21 January 2018

1 reference

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells

21 January 2018

1 reference

Age-dependent effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma.

21 January 2018

1 reference

Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis

21 January 2018

1 reference

Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.

21 January 2018

1 reference

Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study

21 January 2018

1 reference

Effects of low-dose prednisone on bone metabolism

21 January 2018

1 reference

BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice

21 January 2018

1 reference

Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta.

21 January 2018

1 reference

Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF

21 January 2018

1 reference

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro

21 January 2018

1 reference

Essential role of beta-catenin in postnatal bone acquisition

21 January 2018

1 reference

Sclerostin in Mineralized Matrices and van Buchem Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.151

1 reference

12 November 2017

1 reference

PubMed ID

20549703